NIH-funded research NIH-funded research

Exploring how cannabinoids affect HIV in the body

Official title: Defining the impact of cannabinoids on the HIV reservoir in humanized mice

Funded at Univ of North Carolina Chapel Hill · NIH-10933510 · Data updated 2026-11-12

This study is looking at how THC, a compound found in cannabis, affects HIV in mice that have human-like immune systems, to see if it can change how the virus behaves in the body, especially in the brain, which could help us understand its effects for people living with HIV.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniv of North Carolina Chapel Hill
NIH-funded
Lab location1 site (Chapel Hill, United States)
Project startSeptember 30, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$519,071
NIH project number5R61DA059918-02
Project IDNIH-10933510 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV who may be using or considering cannabinoid therapies.

Less likely to help

Patients who are not living with HIV or who do not use cannabinoids are unlikely to benefit from this research.

What this research studies

This research investigates the effects of cannabinoids, specifically THC, on the HIV reservoir in humanized mice. By using a controlled animal model, the study aims to understand how cannabinoid exposure influences HIV characteristics in tissues, particularly in the brain. The research will analyze various doses of THC during different stages of HIV infection and treatment, focusing on viral activity and immune responses. This approach could provide insights into the potential implications of cannabinoid use for people living with HIV.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for managing HIV infection and improving treatment outcomes for patients.

How similar studies have gone: While cannabinoid use among people with HIV is common, this specific investigation into its effects on the HIV reservoir is novel and has not been extensively studied.

Where this research is happening

  • Univ of North Carolina Chapel Hill
    Chapel Hill, United States
    Active

Researchers

  • Principal investigator: Browne, Edward P — Univ of North Carolina Chapel Hill
  • Study coordinator: Browne, Edward P

Related research

Other NIH-funded projects on the same topics.

  • A center for coordinating data related to heart and blood health.

    This study is working on a new system to gather and analyze health information about heart and blood disorders, which could lead to better ways to diagnose and treat these conditions, ultimately helping patients like you.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-9732880

  • Healthy work design and worker well-being

    A multi-site program aims to improve the health and well-being of workers by studying how work design affects safety, stress, and quality of life.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11631666

  • Unified and fair multimodal learning for autoimmune diseases

    A patient-friendly AI approach will combine many kinds of health data to improve diagnosis and personalized care for autoimmune diseases, including lupus.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11625649

  • Structural factors linking minimum wage, COVID-19, and community violence

    A long-term study will explore whether higher minimum wages and pandemic-related economic factors are connected to changes in violence in US communities.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11624218

  • Non-invasive tears biomarker for early Alzheimer's in LMICs

    A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

  • How HPV interacts with our cells' DNA damage system and its effect on cancer

    This project looks at how high-risk HPV uses the body’s DNA repair machinery to replicate and potentially drive cancer, with the goal of finding new antiviral and cancer-fighting approaches for people affected by HPV-related diseases.

    NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11622604

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.